Professor of Surgery, University Pittsburgh
General Surgery
Dr. David L. Bartlett, MD
|
|
Give Review
David Bartlett practices General Surgery. He graduated from University of Texas Medical School. He received 5 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Pittsburgh Magazine", "Top MD" and "Fellow (FACS)". Doctor David L. Bartlett, MD is a published doctor and has 98 publications published. The lastest was: 'Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.' Doctor David L. Bartlett, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Outcomes of CytoreDuctive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
- Effect of a concomitant urologic procedure on outcomes following cytoreDuctive surgery with hyperthermic intraperitoneal chemotherapy.
- Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.
- The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
- Assessment of Quality Outcomes for Robotic Pancreaticoduodenectomy: Identification of the Learning Curve.
- Moving Fast and Moving Slow.
- Robotic surgery for benign duodenal Tumors.
- HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal Cancer cells.
- First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.
- Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenoCarcinoma.
- Institutional Learning Curve of CytoreDuctive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies.
- Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon Cancer cells.
- Analysis of outcomes for single-incision laparoscopic surgery (SILS) right colectomy reveals a minimal learning curve.
- Oncolytic viruses as platform for multimodal Cancer therapeutics: a promising land.
- Does Obesity Affect Outcomes of CytoreDuctive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Disseminated Mucinous Appendiceal Neoplasms?
- Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the deLivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in...
- Regional Delivery of Oncolytic Vaccinia Virus: It's Time for Clinical Trials.
- Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death.
- Clinicopathologic and molecular Analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a thre...
- Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice.
- Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis.
- Impact of Aggressive Histology and Location of Primary Tumor on the Efficacy of Surgical Therapy for Peritoneal Carcinomatosis of ColoRectal Origin.
- Aggressive Locoregional Surgical Therapy for Gastric Peritoneal Carcinomatosis.
- Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular Carcinoma.
- T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.
- 250 robotic Pancreatic resections: safety and feasibility.
- IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of Cancer patients.
- Robotic Versus Laparoscopic Hepatectomy: A Matched Comparison.
- Phase II Study of InDuction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic ...
- Outcome and Prognostic Factors After Adrenalectomy for Patients with Distant Adrenal Metastasis.
- Inhibitors of C5 complement enhance vaccinia virus oncolysis.
- Extensive cytoreDuctive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.
- Resection of isolated local and metastatic recurrence in periampullary adenoCarcinoma.
- A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer.
- Local Administration of TLR Ligands Rescues the Function of Tumor-Infiltrating CD8 T Cells and Enhances the Antitumor Effect of Lentivector Immunization.
- Aggressive locoRegional management of recurrent peritoneal sarcomatosis.
- Treatment factors associated with long-term survival after cytoreDuctive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma.
- A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis.
- A novel nomogram for peritoneal mesothelioma predicts survival.
- Significance of serum tumor marker levels in peritoneal Carcinomatosis of appendiceal origin.
- Life after death: targeting high mobility group box 1 in emergent Cancer therapies.
- Robotic-Assisted Minimally Invasive Central Pancreatectomy: Technique and Outcomes.
- Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique.
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects.
- Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activity.
- NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells.
- The current state of robotic-assisted Pancreatic surgery.
- Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenoCarcinoma following neoadjuvant therapy.
- Mucin as a therapeutic target in pseudomyxoma peritonei.
- Can metastatic colorectal Cancer be cured?
- Single-incision laparoscopic right colectomy in an unselected patient population.
- Lentivector Prime and Vaccinia Virus Vector Boost Generate High-Quality CD8 Memory T Cells and Prevent Autochthonous Mouse Melanoma.
- Dendritic cells in Cancer immunotherapy: vaccines or autologous transplants?
- Homeobox Gene Rhox5 Is Regulated by Epigenetic Mechanisms in Cancer and Stem cells and Promotes Cancer Growth.
- Technical Aspects of Robotic-Assisted Pancreaticoduodenectomy (RAPD).
- Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer.
- C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management.
- Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic Cancer.
- Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of Cancer.
- Robotic-assisted major Pancreatic resection and reconstruction.
- Meckel's diverticulum--a high-risk region for malignancy in the ileum. Insights from a population-based epidemiological study and implications in surgical management.
- InDuction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells...
- Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peri...
- Robotic-assisted major Pancreatic resection.
- Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo coloRectal metastatic rat model.
- Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for coloRectal peritoneal carcinomatosis.
- Effect of hyperthermia in combination with TRAIL on the JNK-Bim signal transDuction pathway and growth of xenograft tumors.
- CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival.
- In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion.
- Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters.
- Reoperation for parathyroid adenoma: a contemporary experience.
- Three epigenetic drugs up-regulate homeobox gene Rhox5 in Cancer cells through overlapping and distinct molecular mechanisms.
- Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.
- Intrahepatic cholangioCarcinoma: a worthy challenge.
- A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal Cancer.
- The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related Hyperparathyroidism.
- Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal Cancer.
- Loss of heterozygosity predicts poor survival after resection of pancreatic adenoCarcinoma.
- Operative management of Cushing syndrome secondary to micronodular Adrenal hyperplasia.
- HIPEC: the complexities of clinical trials.
- Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary Cancer center.
- Clinical, genetic and radiographic Analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).
- Redirecting adaptive immunity against foreign antigens to tumors for Cancer therapy.
- Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.
- High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.
- High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.
- Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix.
- Chemotherapy and regional therapy of hepatic coloRectal metastases: expert consensus statement.
- Intravenous and isolated limb perfusion deLivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates.
- Limited survival in patients with carcinomatosis from foregut malignancies after cytoreDuction and continuous hyperthermic peritoneal perfusion.
- The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.
- Ex Situ resection techniques and liver autotransplantation: last resource for otherwise unresectable malignancy.
- Pancreaticoduodenectomy in the presence of superior mesenteric venous Obstruction.
- Targeting vaccinia to solid Tumors with local hyperthermia.
- Isolated hepatic perfusion for the treatment of patients with colorectal Cancer liver metastases after irinotecan-based therapy.
- Selective inDuction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.
- Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic deLivery using 111In-pentetreotide.
Schools
University of Texas At Houston Medical School At Houston
Procedures Preformed
- Adrenalectomy
- Appendectomy, Open
- Colectomy
- Cystectomy
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- AnoRectal Abscess
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Pittsburgh Magazine
- Top MD
- Fellow (FACS)
Education
-
University of Pennsylvania Health System -
University of Texas Medical School
Hospital
-
UPMC Passavant -
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1952373862 | |
| NPPES Provider LastName | BARTLETT | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 152321309 | |
| NPPES Provider State | PA | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 242.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952373862 |
| Last Name Of The Provider | BARTLETT |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Harry W. Sell Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Perri, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Castillo, MD |
|
|
Dr. Kelly A. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita P. Courcoulas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony Dunne, MD |
|
|
Dr. Madhusudanan Nair, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen L. Engle, MD |
|
|
Dr. Anthony B. Longhini, MD |
|
|
Dr. Elizabeth R. Johnson, MD |
|
|
Dr. Mariano E. Petilla, MD |
|
|
Dr. Howard Semins, MD |